Logo image of PHUN

PHUNWARE INC (PHUN) Stock Fundamental Analysis

NASDAQ:PHUN - Nasdaq - US71948P2092 - Common Stock - Currency: USD

3.25  -0.06 (-1.81%)

After market: 3.3099 +0.06 (+1.84%)

Fundamental Rating

3

PHUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. PHUN has a great financial health rating, but its profitability evaluates not so good. PHUN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PHUN has reported negative net income.
In the past year PHUN has reported a negative cash flow from operations.
PHUN had negative earnings in each of the past 5 years.
PHUN had a negative operating cash flow in each of the past 5 years.
PHUN Yearly Net Income VS EBIT VS OCF VS FCFPHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

PHUN's Return On Assets of -10.49% is in line compared to the rest of the industry. PHUN outperforms 41.84% of its industry peers.
With a Return On Equity value of -11.34%, PHUN perfoms like the industry average, outperforming 49.65% of the companies in the same industry.
Industry RankSector Rank
ROA -10.49%
ROE -11.34%
ROIC N/A
ROA(3y)-295.45%
ROA(5y)-202%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PHUN Yearly ROA, ROE, ROICPHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

The Gross Margin of PHUN (43.61%) is worse than 72.34% of its industry peers.
PHUN's Gross Margin has declined in the last couple of years.
PHUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.33%
GM growth 5Y-2.93%
PHUN Yearly Profit, Operating, Gross MarginsPHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

7

2. Health

2.1 Basic Checks

PHUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHUN has been increased compared to 1 year ago.
PHUN has more shares outstanding than it did 5 years ago.
PHUN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PHUN Yearly Shares OutstandingPHUN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
PHUN Yearly Total Debt VS Total AssetsPHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PHUN has an Altman-Z score of 1.48. This is a bad value and indicates that PHUN is not financially healthy and even has some risk of bankruptcy.
PHUN has a Altman-Z score (1.48) which is in line with its industry peers.
There is no outstanding debt for PHUN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.48
ROIC/WACCN/A
WACC11.68%
PHUN Yearly LT Debt VS Equity VS FCFPHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 15.41 indicates that PHUN has no problem at all paying its short term obligations.
The Current ratio of PHUN (15.41) is better than 96.10% of its industry peers.
A Quick Ratio of 15.41 indicates that PHUN has no problem at all paying its short term obligations.
The Quick ratio of PHUN (15.41) is better than 96.10% of its industry peers.
Industry RankSector Rank
Current Ratio 15.41
Quick Ratio 15.41
PHUN Yearly Current Assets VS Current LiabilitesPHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

PHUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.92%, which is quite impressive.
PHUN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.96%.
PHUN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.13% yearly.
EPS 1Y (TTM)94.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)-32.96%
Revenue growth 3Y-33.08%
Revenue growth 5Y-30.13%
Sales Q2Q%-25.3%

3.2 Future

PHUN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.12% yearly.
Based on estimates for the next years, PHUN will show a quite strong growth in Revenue. The Revenue will grow by 17.30% on average per year.
EPS Next Y30.67%
EPS Next 2Y14.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.7%
Revenue Next 2Y17.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHUN Yearly Revenue VS EstimatesPHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PHUN Yearly EPS VS EstimatesPHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -10 -20 -30

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHUN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHUN Price Earnings VS Forward Price EarningsPHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHUN Per share dataPHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A more expensive valuation may be justified as PHUN's earnings are expected to grow with 14.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.12%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PHUN!.
Industry RankSector Rank
Dividend Yield N/A

PHUNWARE INC

NASDAQ:PHUN (7/11/2025, 8:00:00 PM)

After market: 3.3099 +0.06 (+1.84%)

3.25

-0.06 (-1.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners13.18%
Inst Owner Change0%
Ins Owners0.16%
Ins Owner Change0%
Market Cap65.55M
Analysts80
Price Target6.57 (102.15%)
Short Float %7.12%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.93%
Min EPS beat(2)-41.18%
Max EPS beat(2)69.04%
EPS beat(4)3
Avg EPS beat(4)11.9%
Min EPS beat(4)-41.18%
Max EPS beat(4)69.04%
EPS beat(8)5
Avg EPS beat(8)-29.19%
EPS beat(12)6
Avg EPS beat(12)-36.48%
EPS beat(16)7
Avg EPS beat(16)-98.8%
Revenue beat(2)0
Avg Revenue beat(2)-18.77%
Min Revenue beat(2)-37.5%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-24.44%
Min Revenue beat(4)-50.08%
Max Revenue beat(4)-0.04%
Revenue beat(8)0
Avg Revenue beat(8)-26.81%
Revenue beat(12)0
Avg Revenue beat(12)-45.47%
Revenue beat(16)2
Avg Revenue beat(16)-35.94%
PT rev (1m)1.98%
PT rev (3m)-20.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.36%
EPS NY rev (1m)-10.59%
EPS NY rev (3m)-50.58%
Revenue NQ rev (1m)3.56%
Revenue NQ rev (3m)-31%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-48.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.18
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0.15
BVpS5.14
TBVpS5.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.49%
ROE -11.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.61%
FCFM N/A
ROA(3y)-295.45%
ROA(5y)-202%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.33%
GM growth 5Y-2.93%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.41
Quick Ratio 15.41
Altman-Z 1.48
F-Score4
WACC11.68%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y30.67%
EPS Next 2Y14.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.96%
Revenue growth 3Y-33.08%
Revenue growth 5Y-30.13%
Sales Q2Q%-25.3%
Revenue Next Year-8.7%
Revenue Next 2Y17.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-21.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.85%
OCF growth 3YN/A
OCF growth 5YN/A